Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion

By L. Shields, G. Raque, S. Glassman, M. Campbell, T. Vitaz, J. Harpring, C. Shields. Spine, 2006

708 citations recorded by the source corpus.